EGFR and adenocarcinoma: Yang Z et al. [22] analyzed 60 CLCNEC resected samples using NGS, and found that 23 patients with positive results were all adenocarcinoma-CLCNEC, including 17 cases of EGFR mutation, 4 cases of ALK rearrangement and 2 cases of KRAS mutation.